hit counter
Bioanalytical Systems, Inc. (BASI) Stock News Sentiment & Price - Sentifly
BASI - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Bioanalytical Systems, Inc. (BASI)

USA
Research Services
NASDAQ
BASI Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BASI Latest news
GlobeNewsWire
Neutral
Bioanalytical Systems, Inc. Announces Corporate Name Change to Inotiv, Inc.
2021-03-19 16:05

WEST LAFAYETTE, Ind., March 19, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research services, today announced a change of the Company's corporate name from Bioanalytical Systems, Inc. to Inotiv, Inc.

Zacks Investment Research
Positive
Fed Eyes Faster Recovery in 2021: 3 MedTech Stocks to Buy
2021-03-19 11:11

MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.

GlobeNewsWire
Neutral
Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology
2021-03-17 08:33

WEST LAFAYETTE, Ind., March 17, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced plans to expand the Company's service offerings to add cardiovascular safety pharmacology capabilities to the existing capabilities for respiratory and central nervous system safety pharmacology.

GlobeNewsWire
Neutral
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Additional Vivarium Capacity at Facility in West Lafayette, IN
2021-03-09 08:33

WEST LAFAYETTE, Ind., March 09, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services continues to invest in expanding services and adding capacity to meet client needs and growth expectations. In line with these goals, the Company has been expanding and further developing its West Lafayette vivarium. Last month, the additional West Lafayette capacity was successfully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council. The Company believes this is an important step forward as it remains focused on strategic growth.

GlobeNewsWire
Neutral
Bioanalytical Systems, Inc., doing business as Inotiv, to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference
2021-03-04 08:33

WEST LAFAYETTE, Ind., March 04, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that Robert Leasure, Jr., President and Chief Executive Officer, and Beth Taylor, Vice President of Finance and Chief Financial Officer, are scheduled to participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021. Management will be available for one-on-one meetings throughout both days. A webcast of the presentation will be available on March 9, 2021, at 7:00 a.m. ET through a link that will be posted on the Investors section of the Company's website at  ir.inotivco.com  and will be available for approximately 90 days.

GlobeNewsWire
Neutral
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Laboratory Infrastructure and Data and Study Management Technologies
2021-02-24 08:33

WEST LAFAYETTE, Ind., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced additional investments in laboratory infrastructure and data and study management technologies in order to support the Company's growth strategy and service delivery goals for clients.

GlobeNewsWire
Neutral
Bioanalytical Systems, Inc., doing business as Inotiv, Appoints Greg Beattie as Chief Operating Officer
2021-02-11 16:05

WEST LAFAYETTE, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced the appointment of Greg Beattie as Chief Operating Officer of the Company, effective February 15, 2021.

Seeking Alpha
Neutral
Bioanalytical Systems, Inc. (BASI) CEO Bob Leasure on Q1 2021 Results - Earnings Call Transcript
2021-02-09 22:15

Bioanalytical Systems, Inc. (BASI) CEO Bob Leasure on Q1 2021 Results - Earnings Call Transcript

GlobeNewsWire
Neutral
Bioanalytical Systems, Inc., Announces First Quarter Fiscal 2021 Financial Results
2021-02-09 16:05

WEST LAFAYETTE, Ind., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three months ended December 31, 2020 (“Q1 FY 2021”).

GlobeNewsWire
Neutral
Bioanalytical Systems, Inc., to Report First Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, February 9, 2021
2021-01-26 08:33

WEST LAFAYETTE, Ind., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that the Company will issue its financial results press release for the fiscal 2021 first quarter ended December 31, 2020, on Tuesday, February 9, 2021, after the close of the stock market, and host a conference call the same day at 4:30 p.m. Eastern Time to discuss the results.

Loading more news...